Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company (NYSE:BMY) and has acquired the assets related to FV-100, an orally available nucleoside analogue, currently being developed for the treatment of shingles, a severe, painful skin […]
Read More »Category : Press Releases
Arnall Golden Gregory Adds International Business, Food and Drug Practices to D.C. Office
ATLANTA and WASHINGTON, July 21, 2011, 2011 /PRNewswire/ — Arnall Golden Gregory’s Washington office, which opened in January with a focus on privacy law, has expanded its scope to strengthen the firm’s International Business and Food and Drug practices. Joining Atlanta-based AGG in the nation’s capital are Partners Michael E. Burke and P. Terrence Gaffney […]
Read More »Category : Press Releases
FDA to make enforcement and compliance activities accessible online
The U.S. Food and Drug Administration today announced that it is disclosing more information about inspections and court actions, and now has a web portal1 on its enforcement activities as part of Phase II of the agency’s Transparency Initiative. These actions are being taken to make FDA’s enforcement and compliance-related activities more accessible, downloadable, and […]
Read More »Category : Press Releases
ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock
ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock NATICK, Mass. and SAN FRANCISCO, May 5, 2011 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of its ALTITUDE® Clinical Science program, which demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in […]
Read More »Category : Press Releases
Xlumena Receives CE Mark for Revolutionary AXIOSâ„¢ Stent and Delivery System
Xlumena Receives CE Mark for Revolutionary AXIOSâ„¢ Stent and Delivery System 0 0 0 – Xlumena’s newest innovation is the first stent approved for endoscopic translumenal drainage -A targeted commercial launch is underway in select European markets MOUNTAIN VIEW, Calif., May 5, 2011 /PRNewswire/ — Xlumena, Inc., a privately-held provider of innovative technology for the […]
Read More »Category : Press Releases
Econiche(TM) Vaccine Efficacy Challenge Study Summarized in The Canadian Journal of Veterinary Research
Econiche(TM) Vaccine Efficacy Challenge Study Summarized in The Canadian Journal of Veterinary Research BELLEVILLE, ON, May 5 /PRNewswire-FirstCall/ – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that the results of a controlled challenge study with the Company’s Escherichia coli (E. coli) O157 cattle vaccine -EconicheTM – […]
Read More »Category : Press Releases
MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
WASHINGTON, May 4, 2011 /PRNewswire-USNewswire/ — The Center for Best Practices, a new affiliate organization of Medicaid Health Plans of America (MHPA), today announced the receipt of financial sponsorship from Raritan, NJ-based pharmaceutical company Ortho-McNeil-Janssen Pharmaceuticals, Inc. to engage Medicaid managed care clinical leadership on the best ways to treat plan members with schizophrenia, bipolar […]
Read More »Category : Press Releases
Avanir Pharmaceuticals Announces Landmark ‘PRISM’ Pseudobulbar Affect Patient Registry
Registry will Assess Relationship between PBA and Quality of Life ALISO VIEJO, Calif., May 4, 2011 /PRNewswire/ — Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced the PRISM patient registry, the first patient registry to further quantify the prevalence and quality of life impact of pseudobulbar affect (PBA) in patients with a variety of underlying neurologic […]
Read More »Category : Press Releases
CDISC Standards at Core of FDA Cross Study Clinical Trial Respostiory Project
Standards from the Clinical Data Interchange Standards Consortium (CDISC) were specified in a project recently awarded for development of a Clinical Trial Repository (CTR) for the U.S. Food and Drug Administration (FDA). The FDA is partnering with the National Cancer Institute Center for Biomedical Informatics and Information Technology (NCI CBIIT) to create this CTR to […]
Read More »Category : Press Releases
Boston Scientific Announces CE Mark Approval and First Use of Blazerâ„¢ Open-Irrigated Catheter in Europe
Radiofrequency ablation catheter designed to treat a variety of arrhythmias NATICK, Mass., May 3, 2011 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and first use in Europe of its Blazerâ„¢ Open-Irrigated Catheter, the Company’s latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, […]
Read More »Category : Press Releases
